drugset / Trial / NCT04765137
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
Phase 2
Recruiting
20 enrolled
Johns Hopkins University
The Richman Family Precision Medicine Center of Excellence in Alzheimer Disease · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effect of atorvastatin on brain vessel reactivity and with it on blood flow in people with mild cognitive impairment.
Timeline
- Start
- 2021-05-21
- Primary completion
- 2027-07-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | Oral |